SW
TEVA icon

SkyOak Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

SkyOak Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,262
Closed -$125K – 250
2022
Q1 		$125K Sell
13,262
-10,032
-43% -$83.7K 0.03% 232
2021
Q4 		$187K Hold
23,294
– – 0.05% 232
2021
Q3 		$227K Sell
23,294
-6,163
-21% -$57.7K 0.06% 205
2021
Q2 		$292K Sell
29,457
-1,353
-4% -$14.3K 0.08% 172
2021
Q1 		$312K Sell
30,810
-350
-1% -$4.01K 0.09% 164
2020
Q4 		$301K Buy
+31,160
New +$299K 0.09% 163

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SkyOak Wealth's TEVA Position: Q2 2022 in Review

SkyOak Wealth sold out of Teva Pharmaceuticals (TEVA) in Q2 2022, closing a stake of 13,262 shares — an estimated $125K sold.

SkyOak Wealth first reported a position in TEVA in Q4 2020 and held it in 6 quarters. The position peaked at $312K in Q1 2021. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2022.

  • SkyOak Wealth reported no remaining Teva Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • SkyOak Wealth sold 13,262 Teva Pharmaceuticals shares in Q2 2022, an estimated $125K.
  • SkyOak Wealth first reported a position in Teva Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • SkyOak Wealth's Teva Pharmaceuticals position peaked at $312K in Q1 2021.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2022.

Based on SkyOak Wealth's 13F filing for Q2 2022, filed 26 Jul 2022.